AXT Inc's stock soared 5.05% in pre-market trading on Thursday.
The surge follows positive analyst action and strong institutional confidence. Wedbush boosted its price target on AXT Inc from $28 to $80 while maintaining its Outperform rating. Additionally, the company's underwriters fully exercised the over-allotment option at $64.25 per share, raising approximately $632.5 million in total capital from the recent public offering.
The full exercise of the over-allotment option is viewed as a strong vote of confidence from institutional investors. Proceeds from the offering are earmarked for expanding semiconductor substrate production capacity and strengthening research and development to meet growing demand in 5G, data center, and optoelectronic applications.